Bliss GVS Pharma has received the Establishment Inspection Report (EIR) for its manufacturing unit located at Dewan Udyog Nagar, Aliyali Village, Palghar, Maharashtra, indicating closure of the inspection through which the United States Food and Drug Administration (USFDA) agency assigned the inspection classification of the facility as ‘Voluntary Action Indicated (VAI)’.
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP). Earlier, USFDA had conducted a Pre-Approval Inspection (PAI) and Good Manufacturing Practices at the said manufacturing unit from March 13, 2023, to March 17, 2023.
Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1789.25 |
| Dr. Reddys Lab | 1274.20 |
| Cipla | 1387.50 |
| Zydus Lifesciences | 1088.05 |
| Lupin | 2266.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: